Analysts think ELUT stock price could increase by 186%
Jul 27, 2024, 6:25 AM
7.34%
What does ELUT do
Aziyo Biologics, Inc., a commercial-stage biotechnology company based in Silver Spring, Maryland, specializes in drug-eluting biologic technologies for device implantation and tissue reconstruction. The company, which went public in 2020, develops products like CanGaroo Envelope for cardiac device stabilization and SimpliDerm for breast reconstruction post-mastectomy.
4 analysts think ELUT stock price will increase by 185.98%. The current median analyst target is $10.71 compared to a current stock price of $3.75. The lowest analysts target is $10.10 and the highest analyst target is $11.55.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
